Delivery Order SPE2DR25D3303-SPE2DR26F64B9
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,535.70 to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector, with an ultimate completion date of December 5, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award based on AmerisourceBergen's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The product will be performed at the vendor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors with a ceiling value of $1,451.90 and a firm fixed price. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,485.53 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors on December 10, 2025, with completion due by December 11, 2025. This is a firm fixed price delivery order under a non-set-aside, competitively awarded contract. The product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,116.42 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, issued on December 10, 2025, represents a competitive award with no set-aside designation and calls for completion by December 11, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector supplies, valued at $4,994.93 under a firm fixed-price contract type. The award was made on December 3, 2025, with an ultimate completion date of December 4, 2025. This non-set-aside delivery order represents a small-value pharmaceutical procurement fulfilled by AmerisourceBergen's corporate office, with performance at the company's headquarters in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injectors valued at $5,364.64 under firm fixed-price terms. The award was issued on November 4, 2025, with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-competitive procurement utilizing an existing contract vehicle rather than a new...
- The Defense Logistics Agency awarded a delivery order valued at $3,667.38 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, issued on December 15, 2025, with an ultimate completion date of December 16, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $14,646.60. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $18,468.52 firm fixed price delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 ml auto-injector units, with a completion date of September 11, 2025. The award was made on September 10, 2025, with no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $11,964.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, which carries an ultimate completion date of September 11, 2025, represents a competitively awarded, non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F64B9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units valued at $2,534.04 under a firm fixed price contract type. The order, placed on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-set-aside competitive award. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The Sumatriptan auto-injector procurement supports the Defense Health Agency and other government healthcare customers requiring migraine treatment medications as part of broader pharmaceutical supply initiatives within the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 12/17/25 |